| 000 | 01742 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250517215235.0 | ||
| 264 | 0 | _c20190128 | |
| 008 | 201901s 0 0 eng d | ||
| 022 | _a1090-2430 | ||
| 024 | 7 |
_a10.1016/j.expneurol.2018.05.009 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aVillalón, Eric | |
| 245 | 0 | 0 |
_aInternode length is reduced during myelination and remyelination by neurofilament medium phosphorylation in motor axons. _h[electronic resource] |
| 260 |
_bExperimental neurology _c08 2018 |
||
| 300 |
_a158-168 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S. | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAxons _xphysiology |
| 650 | 0 | 4 | _aDemyelinating Diseases |
| 650 | 0 | 4 | _aEthidium |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 |
_aMotor Neurons _xphysiology |
| 650 | 0 | 4 | _aMutagenesis, Site-Directed |
| 650 | 0 | 4 |
_aMyelin Sheath _xdrug effects |
| 650 | 0 | 4 | _aNeural Conduction |
| 650 | 0 | 4 |
_aNeurofilament Proteins _xgenetics |
| 650 | 0 | 4 | _aPhosphorylation |
| 650 | 0 | 4 |
_aReaction Time _xphysiology |
| 650 | 0 | 4 |
_aRemyelination _xphysiology |
| 650 | 0 | 4 |
_aSchwann Cells _xdrug effects |
| 650 | 0 | 4 |
_aSciatic Nerve _xpathology |
| 700 | 1 | _aBarry, Devin M | |
| 700 | 1 | _aByers, Nathan | |
| 700 | 1 | _aFrizzi, Katie | |
| 700 | 1 | _aJones, Maria R | |
| 700 | 1 | _aLandayan, Dan S | |
| 700 | 1 | _aDale, Jeffrey M | |
| 700 | 1 | _aDowner, Natalie L | |
| 700 | 1 | _aCalcutt, Nigel A | |
| 700 | 1 | _aGarcia, Michael L | |
| 773 | 0 |
_tExperimental neurology _gvol. 306 _gp. 158-168 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.expneurol.2018.05.009 _zAvailable from publisher's website |
| 999 |
_c28401941 _d28401941 |
||